In our experience, the use of G-CSF or granulocyte macrophage colony-stimulating factor (GM-CFS), at a mean dose of 300 μcg/day, was also useful in life-threatening idiosyncratic drug-induced agranulocytosis in the elderly [3,6,15]. The gene discussed is CSF2; the disease is Absence of circulating granulocytes.